Annual ROE
-33.76%
-54.55%-262.39%
31 December 2023
Summary:
Cullinan Oncology annual return on equity is currently -33.76%, with the most recent change of -54.55% (-262.39%) on 31 December 2023. During the last 3 years, it has fallen by -12.80% (-61.07%). CGEM annual ROE is now -119.83% below its all-time high of 170.22%, reached on 01 December 2011.CGEM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-26.54%
+1.83%+6.45%
30 September 2024
Summary:
Cullinan Oncology quarterly return on equity is currently -26.54%, with the most recent change of +1.83% (+6.45%) on 30 September 2024. Over the past year, it has increased by +5.57% (+17.35%). CGEM quarterly ROE is now -160.30% below its all-time high of 44.01%, reached on 30 June 2020.CGEM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGEM ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +17.4% |
| 3 y3 years | -61.1% | -81.2% |
| 5 y5 years | -166.6% | -392.0% |
CGEM ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -262.4% | at low | -211.1% | +17.4% |
| 5 y | 5 years | -149.1% | at low | -160.3% | +29.5% |
| alltime | all time | -119.8% | at low | -160.3% | +29.5% |
Cullinan Oncology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -26.54%(-6.5%) |
| June 2024 | - | -28.37%(-1.0%) |
| Mar 2024 | - | -28.65%(-10.8%) |
| Dec 2023 | -33.76%(-262.4%) | -32.11%(+2.3%) |
| Sept 2023 | - | -31.40%(+16.6%) |
| June 2023 | - | -26.92%(-327.7%) |
| Mar 2023 | - | 11.82%(-43.0%) |
| Dec 2022 | 20.79%(-199.2%) | 20.75%(+0.0%) |
| Sept 2022 | - | 20.74%(-13.1%) |
| June 2022 | - | 23.88%(-234.1%) |
| Mar 2022 | - | -17.81%(+21.6%) |
| Dec 2021 | -20.96% | -14.65%(-6.7%) |
| Sept 2021 | - | -15.70%(-2.9%) |
| June 2021 | - | -16.17%(-27.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -22.40%(-40.5%) |
| Dec 2020 | -26.03%(-151.4%) | -37.65%(+15.3%) |
| Sept 2020 | - | -32.66%(-174.2%) |
| June 2020 | - | 44.01%(+92.1%) |
| Mar 2020 | - | 22.91%(+152.0%) |
| Dec 2019 | 50.66%(-26.3%) | 9.09% |
| Dec 2018 | 68.71%(+21.3%) | - |
| Dec 2016 | 56.66%(+523.3%) | - |
| Dec 2015 | 9.09%(-28.3%) | - |
| Dec 2014 | 12.68%(-83.3%) | - |
| Dec 2013 | 76.14%(+33.3%) | - |
| Dec 2012 | 57.12%(-66.4%) | - |
| Dec 2011 | 170.22%(+170.3%) | - |
| Dec 2010 | 62.97%(-28.8%) | - |
| Dec 2009 | 88.38% | - |
FAQ
- What is Cullinan Oncology annual return on equity?
- What is the all time high annual ROE for Cullinan Oncology?
- What is Cullinan Oncology quarterly return on equity?
- What is the all time high quarterly ROE for Cullinan Oncology?
- What is Cullinan Oncology quarterly ROE year-on-year change?
What is Cullinan Oncology annual return on equity?
The current annual ROE of CGEM is -33.76%
What is the all time high annual ROE for Cullinan Oncology?
Cullinan Oncology all-time high annual return on equity is 170.22%
What is Cullinan Oncology quarterly return on equity?
The current quarterly ROE of CGEM is -26.54%
What is the all time high quarterly ROE for Cullinan Oncology?
Cullinan Oncology all-time high quarterly return on equity is 44.01%
What is Cullinan Oncology quarterly ROE year-on-year change?
Over the past year, CGEM quarterly return on equity has changed by +5.57% (+17.35%)